Article
Assessment of African swine fever vaccine candidate ASFV-G-∆MGF in a reversion to virulence study
29 May 2023
Abstract excerpt
African swine fever (ASF) has gained panzootic dimensions and commercial vaccines are still unavailable. Recently, a series of live attenuated vaccines has raised hope for an efficacious and safe vaccine, among them "ASFV-G-∆MGF". We tested the latter in an in vivo reversion to virulence study in accordance with International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
